+86-2988253271

Contact Us

  • 6th Floor, 2nd Building, Xijing NO.3, XiJing Industrial Park, DianZi Western Street, Xi'an, Shaanxi, China

  • info@gybiotech.com

  • +86-2988253271

Cycloastragenol Solubility

Apr 24, 2025

Cycloastragenol powder is a natural compound derived from Astragalus membranaceus with multiple biological activities, such as anti-inflammatory, antioxidant, and immunomodulatory effects. It holds an important place in traditional Chinese medicine and is widely studied and used in the fields of health products and pharmaceuticals. The solubility of cycloastragenol is a critical factor in its biological activity and pharmacological effects. Understanding its solubility characteristics is essential for its effective delivery and absorption.

This article will explore the solubility of cycloastragenol powder in depth, including its dissolution behavior in water, solvents, and other media. It will also discuss the factors that affect solubility and how solubility impacts its efficacy. The following is a detailed analysis of the solubility of cycloastragenol.

Cycloastragenol powder

Physicochemical Properties of Cycloastragenol

Cycloastragenol is a flavonoid compound with the molecular formula C41H68O14 and a molecular weight of 784.97. It exhibits strong antioxidant, anti-inflammatory, and immunomodulatory effects. Due to its complex structure, cycloastragenol powder has low water solubility. Typically, compounds of this nature have low solubility in water, which may limit their bioavailability and clinical effects.

Solubility in Water

Cycloastragenol 98 powder has low solubility in water, which is common among most flavonoids. Poor water solubility is an important factor affecting its bioavailability. Typically, the solubility of cycloastragenol in water ranges from 0.1 to 0.5 mg/mL, with the specific value influenced by factors such as pH, temperature, and other conditions of the solution.

Due to its low water solubility, the application of cycloastragenol powder in the pharmaceutical field faces certain challenges. For instance, in oral drug formulations, its low solubility may lead to a reduced absorption rate, thereby diminishing its efficacy.

Solubility in Organic Solvents

In contrast to water, cycloastragenol exhibits higher solubility in organic solvents. Its solubility in solvents like ethanol, methanol, and dimethyl sulfoxide (DMSO) is better than in water. This is because the cycloastragenol molecule contains a highly hydrophobic structure, making it more soluble in hydrophobic solvents.

For example, its solubility in ethanol is typically high, exceeding 10 mg/mL, and in DMSO, it is even higher, around 50 mg/mL. Therefore, the solubility of cycloastragenol powder in organic solvents provides more options for the development of pharmaceutical preparations, especially for oral and injectable formulations.

 

Factors Affecting Solubility

The solubility of cycloastragenol is influenced by many factors, including the nature of the solvent, pH value, temperature, and the use of adjuvants.

Solvent Properties

The polarity of the solvent significantly affects cycloastragenol's solubility. Because cycloastragenol powder contains multiple polar groups, it dissolves more readily in polar solvents (such as water, ethanol, and methanol) and less in non-polar solvents (such as n-hexane and benzene).

Cycloastragenol 98 powder

pH Value

The pH value of the solution also affects cycloastragenol's solubility. The sugar moiety in its glycoside structure may undergo hydrolysis or dissociation under different pH conditions.

In an acidic environment, cycloastragenol typically exhibits higher solubility due to strong interactions with hydrogen ions in the solution. Conversely, in an alkaline environment, the hydrolysis of the glycoside portion may lead to the degradation of cycloastragenol powder, reducing its solubility.

Temperature

Temperature is another important factor influencing solubility. Generally, as temperature increases, so does solubility. This is because higher temperatures increase molecular motion, promoting interaction between cycloastragenol and solvent molecules.

Use of Adjuvants

To improve the solubility of cycloastragenol, adjuvants such as surfactants and cosolvents are often employed. These substances can enhance solubility by altering the properties of the solution.

•Surfactants, such as sodium dodecyl sulfate (SDS), can encapsulate cycloastragenol powder by forming micelles, thereby increasing its solubility in water.

•Cosolvents, such as polyethylene glycol (PEG) and dimethyl sulfoxide (DMSO), help dissolve cycloastragenol by increasing the solution's polarity or reducing solvation energy.

 

Solubility Testing Methods

Several methods are used to test the solubility of cycloastragenol:

Saturation Solubility Method:

This is a common method to determine solubility. A certain amount of cycloastragenol powder is added to a known volume of solvent and stirred until no more dissolves to form a saturated solution. The solvent is then removed by filtration or evaporation, and the mass of dissolved cycloastragenol is determined to calculate solubility.

Cycloastragenol Solubility

HPLC:

High-Performance Liquid Chromatography (HPLC) is used to quantitatively analyze cycloastragenol concentrations in a solvent. A standard curve allows for accurate measurement of cycloastragenol in the sample, from which solubility can be inferred.

UV-Vis Spectroscopy:

Since cycloastragenol absorbs ultraviolet light, its solubility can be assessed by measuring absorbance changes at specific wavelengths, from which concentration and solubility are inferred.

 

Application in Medicines and Health Products

The solubility characteristics of cycloastragenol powder significantly impact the development of medicinal and health products, especially oral preparations and injections. Low solubility can reduce its bioavailability and efficacy.

Solid Oral Preparations

For solid oral preparations, such as capsules and tablets, improving cycloastragenol's solubility is essential. Common techniques include using solubility enhancers (e.g., surfactants), micronization, and solid dispersions. These methods can improve both solubility and bioavailability.

Liquid Preparations

In liquid formulations (e.g., oral liquids and injections), the solubility of cycloastragenol powder directly affects the design of its dosage form. By optimizing the solvent system and using cosolvents, solubility can be significantly improved, ensuring the stability and effectiveness of the preparation.

Nano Drug Delivery Systems

Recent advancements in nano drug delivery systems have proven effective in improving drug solubility. By converting cycloastragenol powder into nanoparticles, its solubility and bioavailability can be significantly enhanced. This technology not only aids in the release of cycloastragenol's efficacy but also reduces the risk of side effects.

Cycloastragenol powder is a natural compound with substantial biological activity. However, its low solubility limits its pharmaceutical applications. By selecting appropriate solvents, adjusting pH, and employing nanotechnology, its solubility and bioavailability can be improved, thereby enhancing its effectiveness. Ongoing research aims to explore additional methods to improve cycloastragenol's solubility, promoting its wider use in clinical practice and health products.

 

Guanjie Biotech is a cycloastragenol powder supplier. If you need our products, please contact us at info@gybiotech.com. Our products pass HALAL, KOSHER, ISO9001, and others.

References:

[1]Xiao, C., et al. (2011).Pharmacokinetic studies of cycloastragenol and its metabolites in rats by HPLC–MS/MS.Journal of Pharmaceutical and Biomedical Analysis, 56(5): 1028–1036.

[2]Zhang, W., et al. (2012). Cycloastragenol: A potent telomerase activator with anti-aging properties. Rejuvenation Research, 15(4): 362–368.

[2]Zhou, L., et al. (2015). A cyclodextrin-based inclusion complex to enhance the solubility and stability of cycloastragenol. International Journal of Pharmaceutics, 494(1): 312–320.

[4]Li, M., et al. (2019). Preparation and evaluation of cycloastragenol nanocrystals to improve oral bioavailability. Drug Development and Industrial Pharmacy, 45(2): 197–204.

[5]Chen, J., et al. (2020). Amorphous solid dispersion of cycloastragenol: formulation design and bioavailability study.European Journal of Pharmaceutics and Biopharmaceutics, 146: 57–65.

Send Inquiry